Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of IV PAPAVERINE 80 mg Prior to Propess on Bishop Score and Pain, Double Blinded Randomized Placebo Controlled Trial

NCT06550232 is registered in ClinicalTrials.gov with Western Galilee Hospital-Nahariya as lead sponsor.

NCT NCT06550232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06550232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of IV PAPAVERINE 80 mg Prior to Propess on Bishop Score and Pain, Double Blinded Randomized Placebo Controlled Trial
Lead sponsor
Western Galilee Hospital-Nahariya
Phase
Phase 4
Overall status
Completed
Start date
August 12, 2024
Completion date
March 23, 2025
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

induced vaginal delivery